INNOVATIVE IDEAS ON THE WAY TO MARKET.

^07.05.2025

Daiichi Sankyo becomes “Golden Ticket” sponsor of the Bio^M biotech incubator MAxL

Founding teams can conduct research at MAxL free of charge for one year

The Japanese pharmaceutical company Daiichi Sankyo has become a “Golden Ticket” sponsor of the Bio^M incubator MAxL (Munich Accelerator Life Sciences & Medicine). Through this partnership, Daiichi Sankyo specifically supports emerging biotech start-ups thereby making an important contribution to promoting innovative therapeutic approaches in the biomedical field.

The incubator, managed by Bio^M, is specifically designed to support pre-seed and early-stage start-up teams in the life sciences and healthtech sectors. It is intended to facilitate the translation of scientific findings into market-ready products thereby filling an important gap in the start-up ecosystem.

MAxL's Golden Ticket program enables an outstanding founding team to advance its research work in the incubator's state-of-the-art laboratory and co-working space free of charge for one year. The team also benefits from... [read more]

^01/2025

Enzymatic solutions for a circular economy - Twogee Biotech moved into MAxL

A world where chemical and material production is fully integrated into a sustainable circular economy, contributing to environmental preservation and social well-being. That is the vision of the latest addition to the MAxL: start-up Twogee Biotech... [read more]

^10/2024

A new team joined MAxL at the end of 2024: OmicsDiscoveries

The vision of OmicsDiscoveries is to facilitate and accelerate genetic testing. Through their advanced machine learning-based analysis of RNA sequencing data, they transform raw data into human-readable reports, supporting translational research. We provide an interactive analysis platform that integrates genetic variants, database annotations... [read more]

^10/2024

FLASH Tissue Diagnostics is the latest addition to MAxL

Our latest addition to the MAxL is FLASH Tissue Diagnostics (FLASH TD). FLASH TD developed the technologically disruptive FLASH method, in which the entire lymph node is made transparent while its native 3D structure is preserved. This enables the quantitative detection of tumor cells in the entire... [read more]

^08/2024

Leopard Biosciences joins MAxL to further develop innovative Point-of-Care Diagnostics

Current molecular diagnostics tests are too complex and too expensive to be used at the Point-of-Care. Leopard Biosciences is democratizing molecular diagnostics by developing instrument-free, easy-to-use, multiplex point-of-care tests with short turnaround time and low cost of goods. Leopard tests combine the simplicity... [read more]

^06/2024

MAxL in Martinsried: Bio^M opens new start-up incubator - 8.5 million euros for innovative start-up teams to strengthen biotechnology in Bavaria

Bio^M Biotech Cluster Development GmbH together with State Secretary Tobias Gotthardt has officially opened the start-up incubator "Munich Accelerator Life Sciences & Medicine" (MAxL) in Martinsried. MAxL supports innovative founders in the field of life sciences and medicine... [read more]